Skip to main content
Commentary Environmental Services Health

It may be a cliché but it is true; prevention is better than cure

WHEB Headshots 27
iStock Frogs June 2019 monthly commentary

 

I recently went to a talk titled ‘Fantastic yeasts and where to find them’ by Professor Matthew Fisher1 of Imperial College London. It was part of the first ever Great Exhibition Road Festival2 in London. As it was a science festival, I expected to learn how yeasts can be used in scientific discovery and various applications.

Yet, the talk started with an apocalyptic description of the situation in the frog world. A fatal infectious disease called chytridiomycosis has been decimating frog populations across the globe. The disease was caused by chytrid fungi and first discovered in 1993. Scientists have warned of risk of mass extinction as the fungi have spread across Australia, Europe and the Americas.

A recent study published on Science in March 2019 shows the alarming damage done by chytrid fungi. They have recorded declines of at least 501 amphibian species, or about 1 out of every 16 known to science. 90 species have become extinct in the wild and another 124 species have declined in number by more than 90%.

Scientists believe that the deadly fungi probably emerged in Asia between 50 and 120 years ago. Humans are unwittingly spreading the pathogen around the world with the rise of global trade. It is easy for small frogs to hide out in produce transported by sea. These fungi have damaged global biodiversity more than any other disease ever recorded.

With all this in mind, it was alarming when the speaker then talked about a fungus that could cause serious infection among human beings. The fungus is called Candida auris, which was first identified in 2009. It is usually acquired in hospitals by patients with weakened immune systems. C. auris infections have been reported in over 30 countries. It is likely that such infection has gone unreported in several other countries.

There are three reasons that the US health protection agency (Centre for Disease Control and Prevention, or CDC) is particularly concerned about this fungus: (1) It is often multidrug-resistant; (2) It is difficult to identify with standard laboratory methods; and (3) It has caused outbreaks in healthcare centres.

Prevention and disease control are of utmost importance to combat these kinds of infectious diseases. Preventative care is a key focus in WHEB’s Health theme. Preventative care not only helps to improve quality of life but also typically reduces overall health care costs. Portfolio company Steris is an industry leader in providing sterilisation and microbial reduction services to hospitals and other healthcare providers. Ecolab is another investment which provides innovative solutions for environmental hygiene in a hospital setting.

CDC recommends family members and healthcare workers to wash their hands properly to stop the spread of C. auris. Unfortunately, studies show that healthcare providers clean their hands less than half as much as they should. Ecolab helps to tackle this problem through its Hand Hygiene Program. It not only sells hand hygiene products, but it also provides bespoke solutions and on-site consultation as well as electronic solutions for hygiene monitoring.

As is the case of C. auris infection, rapid diagnosis is important for effective disease control. We invest in a number of companies which provide solutions and equipment to speed up life sciences research, solve complex analytical challenges and improve patient diagnostics. Thermo Fisher provides analytical equipment and assay kits to facilitate a real-time approach for direct detection of C. auris. Agilent develops bioanalysers to assess the quality and quantity of Ribonucleic acid (RNA) samples in the process of RNA extraction and sequencing analysis, which helps scientists to understand the drug resistance of C. auris.

During the talk, I was moved by the wholehearted dedication of scientists. They have endured challenging environments in remote forests for weeks to gather chytrid fungi samples. We should all be grateful for what scientists have done in these areas. They help us understand this world better and protect the environment and society from such potential threats. It is also satisfying to see that a number of WHEB’s investee companies are at the forefront of providing innovative solutions and products to help tackle these significant challenges.

1 https://www.imperial.ac.uk/people/matthew.fisher

2 https://www.greatexhibitionroadfestival.co.uk/

Important Notices:
Risks include: the price of shares (“Shares”) in FP WHEB Sustainability Impact Fund, WHEB Sustainable Impact Fund or WHEB Environmental Impact Fund may increase or decrease and you may not get back the amount originally invested, for reasons including adverse market and foreign exchange rate movements. Past performance does not predict future returns. The Fund invests in equities and is exposed to price fluctuations in the equity markets, and focuses on investments in mid-sized companies in certain sectors so its performance may not correlate closely with the MSCI World Index (the benchmark). For full risks, please see fund prospectus on www.whebgroup.com

 

General: This information, its contents and any related communication (altogether, the “Information”) is issued by WHEB Asset Management LLP (“WHEB Asset Management”). It is intended for information purposes only and does not constitute or form part of any offer or invitation to buy or sell any security including any shares in the FP WHEB Sustainability Impact Fund or WHEB Sustainable Impact Fund, including in the United States. It should not be relied upon to make an investment decision in relation to Shares in the FP WHEB Sustainability Impact Fund or WHEB Sustainable Impact Fund or otherwise; any such investment decision should be made only on the basis of the Fund scheme documents and appropriate professional advice. This Information does not constitute advice of any kind, investment research or a research recommendation, is in summary form and is subject to change without notice. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming shares. WHEB Asset Management has exercised reasonable care in preparing this Information including using reliable sources, however, makes no representation or warranty relating to its accuracy, reliability or completeness or whether any future event may or may not occur. This Information is only made available to recipients who may lawfully receive it in accordance with applicable laws, regulations and rules and binding guidance of regulators. WHEB Asset Management LLP is registered in England and Wales with number OC 341489 and has its registered office at 7 Cavendish Square, London, W1G 0PE. WHEB Asset Management LLP is authorised and regulated by the Financial Conduct Authority with Firm Reference Number 496413.

 

FP WHEB Sustainability Impact Fund

FundRock Partners Limited (formerly Fund Partners Limited) is the Authorised Corporate Director of the Fund and is authorised and regulated by the Financial Conduct Authority with Firm Reference Number 469278 and has its registered office at 6th Floor Bastion House, 140 London Wall, London, EC2Y 5DN. The state of the origin of the Fund is England and Wales. The Representative in Switzerland is ACOLIN Fund Services AG, Leutschenbachstrasse 50, CH-8050 Zurich, whilst the Paying Agent is NPB Neue Privat Bank AG, Limmatquai 1/am Bellevue, P.O. Box, 8024 Zurich . The relevant documents such as the prospectus, the key investor information document (KIIDs), the Articles of Association as well as the annual and semi-annual reports may be obtained free of charge from the Representative in Switzerland.

 

WHEB Sustainable Impact Fund

The Manager of the Fund is FundRock Management Company S.A., authorised and regulated by the Luxembourg regulator to act as UCITS management company and has its registered office at 33, rue de Gasperich, L-5826 Hesperange, Grand-Duchy of Luxembourg. The Representative in Switzerland is ACOLIN Fund Services AG, Leutschenbachstrasse 50, CH-8050 Zurich, whilst the Paying Agent is NPB Neue Privat Bank AG, Limmatquai 1/am Bellevue, P.O. Box, 8024 Zurich. The relevant documents such as the prospectus, the key investor information document (KIIDs), the Articles of Association as well as the annual and semi-annual reports may be obtained free of charge from the representative in Switzerland. The state of the origin of the Fund is Ireland. The Fund is registered for distribution to professional investors in Austria, France, Germany, Italy, Luxembourg, Norway, Singapore, Sweden and the United Kingdom, and is registered for offering to retail investors in Switzerland, Denmark and the Netherlands. The Fund is also available for professional investors in Belgium and Hong Kong. It is not available to investors domiciled in the United States.

 

WHEB Environmental Impact Fund

The Manager of the Fund is FundRock Management Company S.A., authorised and regulated by the Luxembourg regulator to act as UCITS management company and has its registered office at 33, rue de Gasperich, L-5826 Hesperange, Grand-Duchy of Luxembourg. The Fund is registered for distribution to professional investors in the United Kingdom. It is not available to investors domiciled in the United States.

 

The MSCI information may only be used for your internal use, may not be reproduced or re-dissseminated in any form and may not be used as a basis for or a component of any financial instruments or products or indices. None of the MSCI information is intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such. Historical data and analysis should not be taken as an indication or guarantee of any future performance analysis, forecast or prediction. The MSCI information is provided on an “as is” basis and the user of this information assumes the entire risk of any use made of this information. MSCI, each of its affiliates and each other person involved in or related to compiling, computing or creating any MSCI information (collectively, the “MSCI Parties”) expressly disclaims all warranties (including, without limitation, any warranties of originality, accuracy, completeness, timeliness, non-infringement, merchantability and fitness for a particular purpose) with respect to this information. Without limiting any of the foregoing, in no event shall any MSCI Party have any liability for any direct, indirect, special, incidental, punitive, consequential (including, without limitation, lost profits) or any other damages (www.msci.com).

Sign up to impact fund updates

Sign up below to receive email updates on our impact investment funds.
{{ errors[0] }}
{{ errors[0] }}
{{ errors[0] }}
{{ errors[0] }}
{{ errors[0] }}
{{ errors[0] }}
Authorised and regulated by the Financial Conduct Authority Copyright 2024© WHEB. All rights reserved Made by Thursday